Cytological characteristics of histological types of lung cancer by cytomorphometric and flow cytometric analyses using liquid‐based cytology materials

Distinguishing the histological types of lung cancer is essential for determining treatment strategies in clinical practice. In this study, cytomorphological characteristics and proliferative activities were compared among histological types of lung cancer by cytomorphometric and flow cytometric analyses using liquid‐based cytology (LBC) samples.

[1]  J. Shibahara,et al.  Cytomorphometric and flow cytometric analyses using liquid‐based cytology materials in subtypes of lung adenocarcinoma , 2022, Diagnostic cytopathology.

[2]  J. Shibahara,et al.  Optimal Preservations of Cytological Materials Using Liquid-Based Cytology Fixatives for Next-Generation Sequencing Analysis , 2022, Acta Cytologica.

[3]  A. Nicholson,et al.  The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015. , 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  T. Eguchi,et al.  A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor , 2021, Diagnostics.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  Weidong Wang,et al.  Development of a Radiomics Prediction Model for Histological Type Diagnosis in Solitary Pulmonary Nodules: The Combination of CT and FDG PET , 2020, Frontiers in Oncology.

[7]  J. Shibahara,et al.  Subtyping and EGFR mutation testing from blocks of cytological materials, based on liquid‐based cytology for lung cancer at bronchoscopic examinations , 2020, Diagnostic cytopathology.

[8]  B. Lei,et al.  SUVmax of 18FDG PET/CT Predicts Histological Grade of Lung Adenocarcinoma. , 2020, Academic radiology.

[9]  Guangming Lu,et al.  Correlation Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Pathological Subtypes of Invasive Lung Adenocarcinoma and Prognosis , 2019, Front. Oncol..

[10]  Thomas J. Fuchs,et al.  Clinical-grade computational pathology using weakly supervised deep learning on whole slide images , 2019, Nature Medicine.

[11]  D. Aoki,et al.  A Clinical Trial to Verify the Efficiency of the LC-1000 Exfoliative Cell Analyzer as a New Method of Cervical Cancer Screening , 2019, Acta Cytologica.

[12]  Shinsuke Suzuki,et al.  Comprehensive validation of liquid-based cytology specimens for next-generation sequencing in cancer genome analysis , 2019, PloS one.

[13]  J. Shibahara,et al.  Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid‐based cytology , 2019, Diagnostic cytopathology.

[14]  M. L. Fravolini,et al.  Texture Analysis on [18F]FDG PET/CT in Non-Small-Cell Lung Cancer: Correlations Between PET Features, CT Features, and Histological Types , 2019, Molecular Imaging and Biology.

[15]  N. Razavian,et al.  Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.

[16]  M. Nishihira,et al.  Nuclear Morphometry of Lung Squamous Cell Carcinomas in Cytologic Study , 2018, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[17]  J. Ryu.  Faculty Opinions recommendation of The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[18]  K. Shimada,et al.  Evaluation of RNA and DNA extraction from liquid‐based cytology specimens , 2016, Diagnostic cytopathology.

[19]  R. Haba,et al.  Nuclear grade based on transbronchial cytology is an independent prognostic factor in patients with advanced, unresectable non‐small cell lung cancer , 2016, Cancer cytopathology.

[20]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  Wentao Yang,et al.  A novel highly sensitive and specific flow cytometry system for cervical cancer screening. , 2015, Gynecologic oncology.

[22]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[23]  L. Pantanowitz,et al.  Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification , 2015, Cancer cytopathology.

[24]  A. Burke,et al.  Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung , 2014, Diagnostic Pathology.

[25]  W. Travis,et al.  Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  S. Monaco,et al.  Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification , 2013, Cancer Cytopathology.

[27]  T. Goya,et al.  Diffusion-weighted imaging and positron emission tomography in various cytological subtypes of primary lung adenocarcinoma. , 2013, Clinical imaging.

[28]  Prasad S Adusumilli,et al.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma , 2012, Modern Pathology.

[29]  Yukiko Nakamura,et al.  Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma. , 2011, Lung cancer.

[30]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  Masafumi Okada,et al.  Nuclear grading of primary pulmonary adenocarcinomas , 2010, Cancer.

[32]  Manjiri Deshmukh,et al.  Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  Johan Vansteenkiste,et al.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Noguchi,et al.  Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. , 2005, Lung cancer.

[35]  K. Kerr,et al.  Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category , 2000, Journal of clinical pathology.

[36]  K. Inoue,et al.  Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry. , 1997, Cytometry.

[37]  Prabodh K. Gupta,et al.  Distinction between bronchioloalveolar carcinoma and hyperplastic pulmonary proliferations: A cytologic and morphometric analysis , 1997, Diagnostic cytopathology.

[38]  M. Yokozaki,et al.  Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis. , 1996, Modern Pathology.

[39]  N. Shinomiya,et al.  Proliferating cell nuclear antigen and Ki‐67 in lung carcinoma. Correlation with DNA flow cytometric analysis , 1994, Cancer.

[40]  K. Togashi,et al.  Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on 18F FDG-PET/CT , 2019, Annals of Nuclear Medicine.

[41]  H. Saji,et al.  Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. , 2015, Lung cancer.

[42]  Liu Yan-hui,et al.  Interpretation of Pathological Perspective——International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011 .

[43]  D. Terribile,et al.  DNA flow cytometric analysis in patients with operable non-small cell lung carcinoma. , 1993, European Journal of Cardio-Thoracic Surgery.